Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Trelegy Ellipta Inhaler
Manufacturer/Marketed By : GLAXO SMITHKLINE PHARMACEUTICALS LTD
$31.00 $27.90
Trelegy Ellipta inhaler is a combination of three active drugs Fluticasone Furoate + Umeclidinium + Vilanterol. It is used to treat chronic obstructive pulmonary disease (COPD) symptoms such as wheezing,...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
FLUTICASONE FUROATE,UMECLIDINIUM,VILANTEROL
Active Pharmaceutical Ingredient
Trelegy Ellipta Inhaler
31,00$
27,90$
Trelegy Ellipta inhaler is a combination of three active drugs Fluticasone Furoate + Umeclidinium + Vilanterol. It is used to treat chronic obstructive pulmonary disease (COPD) symptoms such as wheezing, shortness of breath, coughing, and chest tightness in adults. It is also indicated to reduce the worsening of COPD in patients with a history of severe breathing symptoms. Fluticasone belongs to the group of drugs known as Corticosteroids. Umeclidinium is in a class of medication called anticholinergics. Vilanterol belongs to a group of drugs known as long-acting beta-agonists (LABAs). The combination of fluticasone, umeclidinium, and vilanterol eases breathing by relaxing and opening airways in the lungs. Trelegy Ellipta Inhaler comes as a powder to inhale by mouth using an inhaler. This medicine should be used regularly as per your doctor's advice. Do not use this if you are allergic to Fluticasone Furoate+Umeclidinium+Vilanterol or any of the other ingredients of this medicine. Inform your doctor if you have any heart, liver, or respiratory problems before starting the treatment. Report to the physician immediately if you have any symptoms of pneumonia or other respiratory disorders after using this medicine. This medicine is not recommended for children or adolescents below the age of 18 years. The most frequent adverse effect of the Trelegy Ellipta inhaler is common cold. Along with this, you could also experience headaches, a cough, a clogged nose, a fungal infection of the mouth, and an infection of the nose. Inform your doctor if any of these adverse effects last longer than expected or develop worse.
Active Pharmaceutical Ingredient
Uses
• Trelegy Ellipta inhaler is approved for long-term maintenance therapy of airflow restriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
• It is also indicated to reduce the worsening of COPD in patients with a history of severe breathing difficulty symptoms.
Benefits
The Trelegy Ellipta inhaler contains fluticasone furoate, a corticosteroid, umeclidinium, an anticholinergic, and vilanterol, a long-acting beta(2)-agonist. Fluticasone furoate inhibits pro-inflammatory signaling molecules by activating the steroid response element and prevents lung airway inflammation brought on by exposure to antigens. Umeclidinium inhibits certain receptors in the smooth muscles of the airway, leading to the dilation of bronchi and bronchioles. Vilanterol increases certain messenger levels in our body, which causes the bronchial smooth muscles to relax.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Increased heart rate
• Increased blood sugar levels
• Decreased potassium levels
• Hypersensitivity reaction
• Fungal infections
• Decreased bone mineral density
• Cataract, glaucoma
• Severe respiratory problems
Common Side Effects
• Cough
• Common cold and upper respiratory infections
• Sore throat
• Diarrhea
• Headache
• Back pain
• Urinary tract infections
• Influenza
How To Use
Your doctor will tell you how much medicine to use. Do not use more than directed. Use this medicine at the same time each day.
Safety Advice
• Breast Feeding: It is unknown whether Trelegy Ellipta inhaler are excreted in human milk. Ask your doctor for advice before taking this medicine. Do not use this medicine if you are breastfeeding or planning to breastfeed unless your doctor tells you to take it.
• Alcohol: It is not known whether it is safe to consume alcohol with the Trelegy Ellipta inhaler. Please consult your doctor.
• Liver: Talk to your doctor before using the Trelegy Ellipta inhaler if you have liver problems.
• Lungs: Talk to your doctor before using the Trelegy Ellipta inhaler if you have liver problems.
• Driving: It is unlikely that Trelegy Ellipta inhaler will affect your ability to drive or use machines. Please consult your doctor for more advice.
• Pregnancy: There is limited data regarding using Trelegy Ellipta inhaler in pregnant women to determine a drug-associated risk. If you are pregnant or think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Do not use this medicine if you are pregnant unless your doctor tells you to take it.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.